Selection and identification of novel peptides specifically targeting human cervical cancer

[1]  Dibson D. Gondim,et al.  Cervical cancer metastasis to the brain: A case report and review of literature , 2017, Surgical neurology international.

[2]  S. Kawakami,et al.  Peptide-Based Cancer-Targeted DDS and Molecular Imaging. , 2017, Chemical & pharmaceutical bulletin.

[3]  N. Gao,et al.  Screening and identification of a specific peptide binding to cervical cancer cells from a phage-displayed peptide library , 2017, Biotechnology Letters.

[4]  L. Rabelo,et al.  Physical Exercise on Inflammatory Markers in Type 2 Diabetes Patients: A Systematic Review of Randomized Controlled Trials , 2017, Oxidative medicine and cellular longevity.

[5]  A. C. de Melo,et al.  A Review of mTOR Pathway Inhibitors in Gynecologic Cancer , 2017, Oxidative medicine and cellular longevity.

[6]  A. Longatto-Filho,et al.  HER Family Receptors are Important Theranostic Biomarkers for Cervical Cancer: Blocking Glucose Metabolism Enhances the Therapeutic Effect of HER Inhibitors , 2017, Theranostics.

[7]  H. Fu,et al.  Increased expression of SKP2 is an independent predictor of locoregional recurrence in cervical cancer via promoting DNA-damage response after irradiation , 2016, Oncotarget.

[8]  Xiaofeng Yang,et al.  A new non-muscle-invasive bladder tumor-homing peptide identified by phage display in vivo , 2016, Oncology reports.

[9]  Jimin Liang,et al.  In vivo quantifying molecular specificity of Cy5.5-labeled cyclic 9-mer peptide probe with dynamic fluorescence imaging. , 2016, Biomedical optics express.

[10]  R. Salani,et al.  Beyond Chemotherapy: An Overview and Review of Targeted Therapy in Cervical Cancer. , 2016, Clinical therapeutics.

[11]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[12]  Xi Cheng,et al.  Advances in diagnosis and treatment of metastatic cervical cancer , 2016, Journal of gynecologic oncology.

[13]  E. Choi,et al.  Application of peptide displaying phage as a novel diagnostic probe for human lung adenocarcinoma , 2016, Amino Acids.

[14]  W. Park,et al.  HER2 as a novel therapeutic target for cervical cancer , 2015, Oncotarget.

[15]  Jamie K. Scott,et al.  Beyond phage display: non-traditional applications of the filamentous bacteriophage as a vaccine carrier, therapeutic biologic, and bioconjugation scaffold , 2015, Front. Microbiol..

[16]  Xiaoqiu Liang,et al.  OSTP as a novel peptide specifically targeting human ovarian cancer. , 2015, Oncology reports.

[17]  Glenn P. Goodrich,et al.  Targeted gold nanoparticles enhance sensitization of prostate tumors to megavoltage radiation therapy in vivo. , 2015, Nanomedicine : nanotechnology, biology, and medicine.

[18]  Jie Tian,et al.  GX1-conjugated poly(lactic acid) nanoparticles encapsulating Endostar for improved in vivo anticolorectal cancer treatment , 2015, International journal of nanomedicine.

[19]  R. Sidman,et al.  Selection and identification of ligand peptides targeting a model of castrate-resistant osteogenic prostate cancer and their receptors , 2015, Proceedings of the National Academy of Sciences.

[20]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[21]  H. Fine,et al.  Molecular characterizations of glioblastoma, targeted therapy, and clinical results to date , 2015, Cancer.

[22]  E. C. Coimbra,et al.  Prospects of molecularly-targeted therapies for cervical cancer treatment. , 2015, Current drug targets.

[23]  E. Choi,et al.  Novel peptides functionally targeting in vivo human lung cancer discovered by in vivo peptide displayed phage screening , 2015, Amino Acids.

[24]  R. Pestell,et al.  The potential to target CCL5/CCR5 in breast cancer , 2014, Expert opinion on therapeutic targets.

[25]  C. Lhommé,et al.  Thérapies ciblées dans les cancers du col de l’utérus en évolution locale ou métastatique , 2014 .

[26]  Xiaoqi Liu,et al.  Trop2 gene: a novel target for cervical cancer treatment , 2014, Journal of Cancer Research and Clinical Oncology.

[27]  Jian Wang,et al.  Targeting osteosarcoma vasculature with peptide obtained by phage display , 2014, Contemporary oncology.

[28]  H. Seol,et al.  Cytotoxic and targeted systemic therapy in advanced and recurrent cervical cancer: experience from clinical trials. , 2014, The Tohoku journal of experimental medicine.

[29]  S. H. van der Burg,et al.  The need for improvement of the treatment of advanced and metastatic cervical cancer, the rationale for combined chemo-immunotherapy. , 2014, Anti-cancer agents in medicinal chemistry.

[30]  A. Leary,et al.  [Targeted therapy in locally and metastatic recurrent cervical cancers]. , 2014, Bulletin du cancer.

[31]  G. Yin,et al.  A novel peptide specifically targeting ovarian cancer identified by in vivo phage display , 2013, Journal of peptide science : an official publication of the European Peptide Society.

[32]  H. Chung,et al.  Impact of Chemoradiation on Prognosis in Stage IVB Cervical Cancer with Distant Lymphatic Metastasis , 2013, Cancer research and treatment : official journal of Korean Cancer Association.

[33]  C. Mathers,et al.  GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer , 2013 .

[34]  J. Gershoni,et al.  A general insert label for peptide display on chimeric filamentous bacteriophages , 2011, Analytical Biochemistry.

[35]  Xin-guo Jiang,et al.  Identification of peptide sequences that target to the brain using in vivo phage display , 2012, Amino Acids.

[36]  Peter S. Conti,et al.  Evaluation of 64Cu Labeled GX1: A Phage Display Peptide Probe for PET Imaging of Tumor Vasculature , 2012, Molecular Imaging and Biology.

[37]  D. Morris,et al.  Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer , 2011, Cancer and Metastasis Reviews.

[38]  Liang Feng,et al.  Targeting the brain with PEG-PLGA nanoparticles modified with phage-displayed peptides. , 2011, Biomaterials.

[39]  A. Zhu,et al.  Development of molecularly targeted therapies in biliary tract cancers: Reassessing the challenges and opportunities , 2011, Hepatology.

[40]  Peter S. Conti,et al.  A Cy5.5-labeled phage-displayed peptide probe for near-infrared fluorescence imaging of tumor vasculature in living mice , 2011, Amino Acids.

[41]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[42]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[43]  Thomas D. Wang,et al.  Affinity peptide for targeted detection of dysplasia in Barrett's esophagus. , 2010, Gastroenterology.

[44]  K. Brown.  Peptidic tumor targeting agents: the road from phage display peptide selections to clinical applications. , 2010, Current pharmaceutical design.

[45]  L. Trusolino,et al.  Activation of HER family members in gastric carcinoma cells mediates resistance to MET inhibition , 2010, Molecular Cancer.

[46]  Li Wang,et al.  A novel peptide (GX1) homing to gastric cancer vasculature inhibits angiogenesis and cooperates with TNF alpha in anti-tumor therapy , 2009, BMC Cell Biology.

[47]  S. Deutscher,et al.  In vivo bacteriophage display for the discovery of novel peptide-based tumor-targeting agents. , 2009, Methods in molecular biology.

[48]  S. Deutscher,et al.  Phage peptide display. , 2008, Handbook of experimental pharmacology.

[49]  R. Kannan,et al.  Targeted Gold Nanoparticles for Imaging and Therapy , 2007 .

[50]  A. Merlo,et al.  Design, construction, and characterization of a large synthetic human antibody phage display library , 2005, Proteomics.

[51]  Philip Robinson,et al.  Identification using phage display of peptides promoting targeting and internalization into HPV‐transformed cell lines , 2005, Journal of molecular recognition : JMR.

[52]  Liu Hong,et al.  Characterization of a specific phage-displayed peptide binding to vasculature of human gastric cancer , 2004, Cancer biology & therapy.

[53]  Wadih Arap,et al.  In vivo phage display and vascular heterogeneity: implications for targeted medicine. , 2002, Current opinion in chemical biology.

[54]  K. A. Noren,et al.  Construction of high-complexity combinatorial phage display peptide libraries. , 2001, Methods.

[55]  I J Das,et al.  Gold microspheres: a selective technique for producing biologically effective dose enhancement. , 2000, International journal of radiation biology.

[56]  M. Zwick,et al.  Phage-displayed peptide libraries. , 1998, Current opinion in biotechnology.

[57]  Erkki Ruoslahti,et al.  Organ targeting In vivo using phage display peptide libraries , 1996, Nature.